Potential of Bryophyllum pinnatum as a Detrusor Relaxant: An in Vitro Exploratory Study

Abstract

An earlier prospective, randomised, placebo-controlled clinical trial had suggested that Bryophyllum pinnatum might have potential in the treatment of overactive bladder. Here we investigated the effects of B. pinnatum leaf press juice, fractions enriched in flavonoids and bufadienolides, and a flavonoid aglycon mixture and individual aglycons on detrusor contractility as a major target in overactive bladder treatment. The strength of the detrusor contractions was investigated using porcine muscle strips stimulated with KCl. B. pinnatum leaf press juice increased the contraction force of muscle strips. Treatment with the flavonoid-enriched fraction had almost no effect on contractility, while the bufadienolide-enriched fraction and flavonoid aglycons led to a concentration-dependent lowering of the contraction force. The data indicate that several components of B. pinnatum leaf press juice may contribute to the inhibitory effect on detrusor contractility, which in turn provides support to overactive bladder treatment with B. pinnatum.

Key words

Bryophyllum pinnatum - Kalanchoe pinnata - Crassulaceae - overactive bladder - bufadienolides - flavonoids - flavonoid aglycons

• References

• 1 Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010; 21: 5-26
• 2 Milsom I, Coyne KS, Nicholson S, Kvasz M, Chen CI, Wein AJ. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol 2014; 65: 79-95
• 3 Nambiar A, Lucas M. Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). Neurourol Urodyn 2014; 33 (Suppl. 03) S21-S25
• 4 Gormley EA, Lightner DJ, Faraday M, Vasavada SP. American Urological Association, Society of Urodynamics, Female Pelvic Medicine. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 2015; 193: 1572-1580
• 5 Slavin SL, Rogers RG, Komesu Y, Omotosho T, Hammil S, Lewis C, Sapien R. Complementary and alternative medicine (CAM) use in women with pelvic floor disorders: a cohort study. Int Urogynecol J 2010; 21: 431-437
• 6 Fürer K, Simões-Wüst AP, von Mandach U, Hamburger M, Potterat O. Bryophyllum pinnatum and related species used in anthroposophic medicine: constituents, pharmacological activities, and clinical efficacy. Planta Med 2016; 82: 930-941
• 7 Kienle GS, Albonico HU, Baars E, Hamre HJ, Zimmermann P, Kiene H. Anthroposophic medicine: an integrative medical system originating in europe. Glob Adv Health Med 2013; 2: 20-31
• 8 Fürer K, Simões-Wüst AP, Winkler A, Amsler N, Schnelle M, von Mandach U. [The application of Bryophyllum pinnatum preparations in obstetrics and gynaecology – a multicenter, prospective observational study]. Forsch Komplementmed 2015; 22: 231-236
• 9 Betschart C, von Mandach U, Seifert B, Scheiner D, Perucchini D, Fink D, Geissbuhler V. Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine 2013; 20: 351-358
• 10 Fürer K, Raith M, Brenneisen R, Mennet M, Simões-Wüst AP, von Mandach U, Hamburger M, Potterat O. Two new flavonol glycosides and a metabolite profile of Bryophyllum pinnatum, a phytotherapeutic used in obstetrics and gynaecology. Planta Med 2013; 79: 1565-1571
• 11 Oufir M, Seiler C, Gerodetti M, Gerber J, Fürer K, Mennet-von Eiff M, Elsas SM, Brenneisen R, von Mandach U, Hamburger M, Potterat O. Quantification of bufadienolides in Bryophyllum pinnatum leaves and manufactured products by UHPLC-ESIMS/MS. Planta Med 2015; 81: 1190-1197
• 12 Wagner H, Lotter H, Fischer M. [The toxic and sedative bufadienolides of Kalanchoe daigremontiana Hamet et Perr]. Helv Chim Acta 1986; 69: 359-367
• 13 McKenzie RA, Franke FP, Dunster PJ. The toxicity to cattle and bufadienolide content of six Bryophyllum species. Aust Vet J 1987; 64: 298-301
• 14 Benavente-Garcia O, Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 2008; 56: 6185-6205
• 15 Gwehenberger B, Rist L, Huch R, von Mandach U. Effect of Bryophyllum pinnatum versus fenoterol on uterine contractility. Eur J Obstet Gynecol Reprod Biol 2004; 113: 164-171
• 16 Wächter R, Brenneisen R, Hamburger M, Mennet M, Schnelle M, Worel AM, Simões-Wüst AP, von Mandach U. Leaf press juice from Bryophyllum pinnatum (Lamarck) Oken induces myometrial relaxation. Phytomedicine 2011; 19: 74-82
• 17 Simões-Wüst AP, Grãos M, Duarte CB, Brenneisen R, Hamburger M, Mennet M, Ramos MH, Schnelle M, Wächter R, Worel AM, von Mandach U. Juice of Bryophyllum pinnatum (Lam.) inhibits oxytocin-induced increase of the intracellular calcium concentration in human myometrial cells. Phytomedicine 2010; 17: 980-986
• 18 Schuler V, Suter K, Fürer K, Eberli D, Horst M, Betschart C, Brenneisen R, Hamburger M, Mennet M, Schnelle M, Simões-Wüst AP, von Mandach U. Bryophyllum pinnatum inhibits detrusor contractility in porcine bladder strips – a pharmacological study towards a new treatment option of overactive bladder. Phytomedicine 2012; 19: 947-951
• 19 Fürer K, Eberli D, Betschart C, Brenneisen R, De Mieri M, Hamburger M, Mennet-von Eiff M, Potterat O, Schnelle M, Simões-Wüst AP, von Mandach U. Inhibition of porcine detrusor contractility by the flavonoid fraction of Bryophyllum pinnatum – a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome. Phytomedicine 2015; 22: 158-164
• 20 Rodriguez-Mateos A, Vauzour D, Krueger CG, Shanmuganayagam D, Reed J, Calani L, Mena P, Del Rio D, Crozier A. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol 2014; 88: 1803-1853
• 21 Badawi JK, Uecelehan H, Hatzinger M, Michel MS, Haferkamp A, Bross S. Relaxant effects of beta-adrenergic agonists on porcine and human detrusor muscle. Acta Physiol Scand 2005; 185: 151-159
• 22 DʼAgostino G, Maria Condino A, Calvi P. Involvement of β3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: Direct evidence by [³H]-acetylcholine release experiments in the isolated detrusor. Eur J Pharmacol 2015; 758: 115-122
• 23 Gründemann C, Diegel C, Sauer B, Garcia-Kaufer M, Huber R. Immunomodulatory effects of preparations from anthroposophical medicine for parenteral use. BMC Complement Altern Med 2015; 15: 219
• 24 Wu SH, Bau DT, Hsiao YT, Lu KW, Hsia TC, Lien JC, Ko YC, Hsu WH, Yang ST, Huang YP, Chung JG. Bufalin induces apoptosis in vitro and has antitumor activity against human lung cancer xenografts in vivo . Environ Toxicol 2017; 32: 1305-1317
• 25 Rather MA, Bhat BA, Qurishi MA. Multicomponent phytotherapeutic approach gaining momentum: Is the “one drug to fit all” model breaking down?. Phytomedicine 2013; 21: 1-14